Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric CancerP.J. Slavish, Philip M. Potter, Liying Chi et al.|Cancer Research|2020Cited by 43
HER2 amplification and overexpression between primary and liver metastatic breast cancer: Significance and implication.Casey Williams, Brian Leyland‐Jones, Brigitte Cyr et al.|Journal of Clinical Oncology|2014Cited by 0
P068 Sequencing to identify potential targets of resistance to primary therapyCrystal Williams, B Leyland-Jones, P. De et al.|The Breast|2015Cited by 0
Investigating the Utility of comprehensive genomic Profiling for patients with newly diagnosed breast cancer.Casey Williams, Brian Leyland‐Jones, Robert B. Goldberg et al.|Journal of Clinical Oncology|2016Cited by 0
Supplementary Data from Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric CancerP.J. Slavish, Philip M. Potter, Liying Chi et al.|Unknown|2023Cited by 0